Progress in Cardiovascular Diseases

Papers
(The H4-Index of Progress in Cardiovascular Diseases is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
CTA in roadmapping post-CABG evaluation324
List of recent issues208
Table of contents189
Emerging tracers for cardiac imaging: Innovations and clinical implications120
Updates in fluorodeoxyglucose positron emission tomography (18FDG-PET) in the diagnosis and management of cardiac sarcoidosis85
Cover 2 (Masthead)84
Table of contents80
Cover 2 (Masthead)73
Cover 2 (Masthead)57
Use of mechanical circulatory support in high-risk percutaneous coronary interventions54
List of recent issues48
Shelter from the cytokine storm: Healthy living is a vital preventative strategy in the COVID-19 era45
Table of contents45
Revisiting high-density lipoprotein cholesterol in cardiovascular disease: Is too much of a good thing always a good thing?44
Handgrip strength asymmetry increases risk of all-cause and cardiovascular mortality: A dose-response analysis across 28 countries44
Chronic thrombosis of bioprostheses: Diagnosis and management44
Estrogen and cardiovascular disease41
Multimodality imaging of hypertrophic cardiomyopathy41
Association of polypill therapy with cardiovascular outcomes, mortality, and adherence: A systematic review and meta-analysis of randomized controlled trials40
Updates on obesity and the obesity paradox in cardiovascular diseases39
Evidence to support health system prioritization of health behaviors in the COVID-19 era37
List of recent issues36
The weekly mortality for ischemic heart disease in the US still peaks on mondays35
A meta-analysis of direct oral anticoagulants vs warfarin for left ventricular thrombus35
List of recent issues35
Editorial Board35
Assessment of lifestyle-related risk factors enhances the effectiveness of cardiac stress testing34
Cover 2 (Masthead)34
Using cardiorespiratory fitness assessment to identify pathophysiology in long COVID – Best practice approaches34
Patient reported outcomes in obstructive hypertrophic cardiomyopathy undergoing myectomy: Results from SPIRIT-HCM study33
Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know33
Supervised exercise therapy for patients with peripheral artery disease: Clinical update and pathways forward32
Normative values for body composition in 22,191 healthy Norwegian adults 20–99 years: The HUNT4 study32
0.27559399604797